Bruker Corp (BRKR)
82.20
-0.26
(-0.32%)
USD |
NASDAQ |
Apr 24, 16:00
82.19
-0.01
(-0.01%)
After-Hours: 20:00
Bruker Free Cash Flow: 243.20M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 243.20M |
| September 30, 2023 | 206.10M |
| June 30, 2023 | 200.70M |
| March 31, 2023 | 148.90M |
| December 31, 2022 | 145.20M |
| September 30, 2022 | 118.50M |
| June 30, 2022 | 114.30M |
| March 31, 2022 | 175.90M |
| December 31, 2021 | 190.40M |
| September 30, 2021 | 254.40M |
| June 30, 2021 | 311.60M |
| March 31, 2021 | 303.80M |
| December 31, 2020 | 235.00M |
| September 30, 2020 | 168.80M |
| June 30, 2020 | 140.20M |
| March 31, 2020 | 141.30M |
| December 31, 2019 | 140.40M |
| September 30, 2019 | 144.40M |
| June 30, 2019 | 124.30M |
| March 31, 2019 | 158.80M |
| December 31, 2018 | 190.50M |
| September 30, 2018 | 169.80M |
| June 30, 2018 | 178.80M |
| March 31, 2018 | 124.90M |
| December 31, 2017 | 110.70M |
| Date | Value |
|---|---|
| September 30, 2017 | 99.10M |
| June 30, 2017 | 101.10M |
| March 31, 2017 | 136.80M |
| December 31, 2016 | 93.70M |
| September 30, 2016 | 152.20M |
| June 30, 2016 | 169.80M |
| March 31, 2016 | 151.70M |
| December 31, 2015 | 195.00M |
| September 30, 2015 | 119.00M |
| June 30, 2015 | 77.90M |
| March 31, 2015 | 92.50M |
| December 31, 2014 | 80.50M |
| September 30, 2014 | 140.70M |
| June 30, 2014 | 165.40M |
| March 31, 2014 | 136.80M |
| December 31, 2013 | 94.70M |
| September 30, 2013 | 40.20M |
| June 30, 2013 | -7.20M |
| March 31, 2013 | 34.30M |
| December 31, 2012 | 60.30M |
| September 30, 2012 | 66.00M |
| June 30, 2012 | 96.30M |
| March 31, 2012 | 58.60M |
| December 31, 2011 | 26.10M |
| September 30, 2011 | 34.50M |
Free Cash Flow Range, Past 5 Years
114.30M
Minimum
Jun 2022
311.60M
Maximum
Jun 2021
184.60M
Average
168.80M
Median
Sep 2020
Free Cash Flow Benchmarks
| Azenta Inc | 32.43M |
| Harvard Bioscience Inc | 11.72M |
| Bionano Genomics Inc | -126.87M |
| Akoya Biosciences Inc | -54.55M |
| Singular Genomics Systems Inc | -74.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 205.50M |
| Cash from Investing (Quarterly) | -36.80M |
| Cash from Financing (Quarterly) | -59.90M |
| Free Cash Flow Per Share (Quarterly) | 1.189 |
| Free Cash Flow to Equity (Quarterly) | 112.10M |
| Free Cash Flow to Firm (Quarterly) | 175.95M |
| Free Cash Flow Yield | 2.01% |